View Exam | PowerPak

1. The National Comprehensive Cancer Network (NCCN) defines FN as a single temperature of ≥38.3°C orally or ≥38.0°C over 1 hour with a neutrophil count of

A. <500 neutrophils/µL or <1000 neutrophils/µL and expected to fall to <500 neutrophils/µL within 48 hours. B. <1500 neutrophils/µL and expected to fall to <1000 neutrophils/µL within 48 hours C. <2000 neutrophils/µL D. <5000 neutrophils/µL

2. Myeloid colony-stimulating factors (CSFs) are recommended for primary prophylaxis in cancer patients receiving chemotherapy who have a risk of FN of

A. ≥10% B. ≥20% C. ≥30% D. ≥40%

3. Which of the following is considered a risk factor for FN in patients receiving myelosuppressive chemotherapy?

A. Age ≥55 years B. Elevated serum iron C. Poor performance status D. Hepatitis C infection

4. Myeloid CSFs

A. decrease the incidence of FN and overall mortality when used for prophylaxis in high risk patients B. improve response to chemotherapy in advanced non-small cell lung cancer C. improve survival in patients with established FN D. do all of the above

5. Short-acting myeloid CSFs

A. are indicated for the treatment of established FN B. should be dosed within 24 hours of chemotherapy administration C. should continue daily until the post-nadir neutrophil count is normal or approaches normal D. All of the above

6. Which of the following contribute to the high cost burden associated with FN?

A. Use of novel cytotoxic regimens B. Use of myeloid CSF therapy in patients at high risk of FN C. Inappropriate addition of myeloid CSF in stable patients with established FN D. Use of long-acting filgrastim (pegfilgrastim) in the outpatient setting

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. The National Comprehensive Cancer Network (NCCN) defines FN as a single temperature of ≥38.3°C orally or ≥38.0°C over 1 hour with a neutrophil count of

2. Myeloid colony-stimulating factors (CSFs) are recommended for primary prophylaxis in cancer patients receiving chemotherapy who have a risk of FN of

3. Which of the following is considered a risk factor for FN in patients receiving myelosuppressive chemotherapy?

4. Myeloid CSFs

5. Short-acting myeloid CSFs

6. Which of the following contribute to the high cost burden associated with FN?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. The National Comprehensive Cancer Network (NCCN) defines FN as a single temperature of ≥38.3°C orally or ≥38.0°C over 1 hour with a neutrophil count of

2. Myeloid colony-stimulating factors (CSFs) are recommended for primary prophylaxis in cancer patients receiving chemotherapy who have a risk of FN of

3. Which of the following is considered a risk factor for FN in patients receiving myelosuppressive chemotherapy?

4. Myeloid CSFs

5. Short-acting myeloid CSFs

6. Which of the following contribute to the high cost burden associated with FN?

« Return to Activity

Customers who Purchased
this Activity also Purchased